Phase II study of oxaliplatin (O) and bevacizumab (B) chemotherapy in refractory germ cell tumors (GCT). Correlation between quality of prostate biopsy and pathological diagnosis in the REDUCE study ...
Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results